CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH) that has attracted substantial interest in the peptide research community for its ability to engage GHRH receptors with notably extended binding kinetics. Unlike native GHRH(1–44), which is rapidly cleared by plasma dipeptidyl peptidase IV (DPP-IV), CJC-1295 incorporates strategic amino acid substitutions and, in its DAC-bearing […]

BPC-157, a synthetic pentadecapeptide derived from a protective gastric protein, has attracted considerable attention in preclinical research circles not only for its broad biological activity but also for the nature of its observed tolerability in animal models. As research interest in this compound continues to expand, investigators have begun scrutinizing what the existing preclinical literature […]

Semax is a synthetic heptapeptide derived from the N-terminal fragment of adrenocorticotropic hormone (ACTH), specifically the ACTH(4–7) sequence extended with a Pro-Gly-Pro tripeptide. Originally developed in Russian research institutions during the 1980s and 1990s, Semax has since attracted significant preclinical interest globally for its interactions with neurotrophic signaling pathways, particularly those involving brain-derived neurotrophic factor […]

TB-500 is a synthetic analog of the naturally occurring peptide Thymosin Beta-4 (Tβ4), a ubiquitous 43-amino acid protein found in virtually every cell of the body. As a research compound, TB-500 has attracted considerable scientific attention due to its ability to bind G-actin (monomeric actin) and modulate actin dynamics — a process central to cell […]

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring copper-binding tripeptide that has attracted significant scientific attention across multiple research domains. First isolated from human plasma in the early 1970s by Loren Pickart, GHK-Cu research has expanded well beyond its origins to encompass investigations into wound healing biology, skin tissue remodeling, antioxidant activity, and gene expression […]

MOTS-C is a mitochondria-derived peptide that has captured significant attention in the research community since its identification in 2015. Unlike the vast majority of bioactive peptides, which are encoded in the nuclear genome, MOTS-C is encoded within the mitochondrial 12S rRNA gene — making it one of a rare class of mitochondrial open reading frame […]

The GLOW peptide stack represents a multi-component research formulation combining four well-studied peptides — GHK-Cu (copper tripeptide), BPC-157, TB-500 (Thymosin Beta-4 fragment), and KPV — into a single nasal spray format. Each constituent has been independently investigated across numerous preclinical models, with research spanning tissue biology, cellular signaling, and systemic regulatory pathways. The convergence of […]

PT-141, also referred to in the scientific literature as bremelanotide, is a synthetic cyclic heptapeptide that has attracted considerable attention in peptide research circles for its interactions with the melanocortin receptor system. Derived from the naturally occurring alpha-melanocyte-stimulating hormone (α-MSH), PT-141 has been investigated primarily in preclinical models for its ability to engage central melanocortin […]

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protein found in gastric juice. Composed of 15 amino acids, this compound has attracted considerable attention in preclinical research circles due to its apparent pleiotropic activity across multiple biological systems. Studies have investigated BPC-157 in animal models spanning gastrointestinal biology, musculoskeletal tissue, neurological signaling, […]